Comment on: A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis

Rheumatology (Oxford). 2014 Jun;53(6):1154-5. doi: 10.1093/rheumatology/keu142. Epub 2014 Mar 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Immunoglobulin Fab Fragments / adverse effects*
  • Immunosuppressive Agents / adverse effects*
  • Lung Diseases, Interstitial / chemically induced*
  • Polyethylene Glycols / adverse effects*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunoglobulin Fab Fragments
  • Immunosuppressive Agents
  • Polyethylene Glycols